Bisphosphonate-Induced Orbital Cellulitis in a Patient With Suspected Parathyroid Carcinoma: A Case Report.

McKenna, Teodora; McKenna, Dominic E; Fernandes, Vinson; Korda, Marian; Bradley, Una

McKenna, Teodora; McKenna, Dominic E; Fernandes, Vinson; Korda, Marian; Bradley, Una.

Afiliación

McKenna T; Otolaryngology - Head and Neck Surgery, Queen's University Medical School, Belfast, GBR.
McKenna DE; Otolaryngology - Head and Neck Surgery, Southern Health and Social Care Trust, Craigavon, GBR.
Fernandes V; Otolaryngology - Head and Neck Surgery, Southern Health and Social Care Trust, Craigavon, GBR.
Korda M; Otolaryngology - Head and Neck Surgery, Southern Health and Social Care Trust, Craigavon, GBR.
Bradley U; Endocrinology, Southern Health and Social Care Trust, Craigavon, GBR.

Cureus ; 16(7): e63577, 2024 Jul.

Article en En | MEDLINE | ID: mdl-39087171

ABSTRACT

ABSTRACT

Bisphosphonates are widely used for a number of metabolic bone conditions. Orbital inflammation is a very rare side effect of bisphosphonate therapy that can risk permanent visual loss. We describe the complex case and successful treatment of a 79-year-old man who developed orbital cellulitis following the use of intravenous pamidronate disodium for severe hypercalcaemia. The challenges regarding the diagnosis of parathyroid carcinoma are also discussed.

Palabras clave

bisphosphonates; geriatrics; hypercalcaemia; hyperparathyroidism; orbital cellulitis; orbital compartment syndrome; parathyroid adenoma; parathyroid carcinoma; pathology; rare

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article